Asia-Pacific Point-of-Care Testing (POCT) Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2027

Asia-Pacific Point-of-Care Testing (POCT) Market, By Product (Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing and Other POC Products), Application (Blood Transfusion, Cardiac Monitoring, Coagulation, Blood Glucose, Haematology, Non- Invasive SPO2 Monitoring, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, Vital Sign Monitoring and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays), Prescription Mode (Prescription-Based Testing and OTC Testing), Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays and Hematology), End-User (Hospitals, Clinics, Laboratories, Home Care, Ambulatory Surgery Centers and Others), Distribution Channel (Direct Tender and Retail Pharmacies), Country (China, Japan, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines and Rest of Asia-Pacific) Industry Trends and Forecast to 2027

Access Full Report @

Asia-Pacific Point-of-Care Testing (POCT) Market

Data Bridge Market Research

Office Number 402, Amanora Chambers, Magarpatta Road,

Hadapsar Pune – 411028.


Client Testimonials